Endothelial-Dependent Fibrinolysis in Subjects with the Lupus Anticoagulant and Thrombosis
Authors:
- 1 January 1988
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 59 (03) , 412-414
Abstract
To investigate the hypothesis that diminished endothelial fibrinolytic activity contributes to the pathogenesis of thrombosis in patients with the lupus anticoagulant (LA), we assessed the ability of endothelium to release tissue-type plasminogen activator (t-PA) in response to standardized venous occlusion (VO) of the arm, and the extent of inhibition of t-PA, in 11 subjects with LA and a history of thrombosis and in 36 healthy normal subjects. The mean rise in plasma t-PA antigen after VO, the mean plasma free t-PA activity after VO, and the mean plasma t-PA inhibitor level prior to VO were not significantly different in subjects with LA and thrombosis and in normal subjects. Four subjects with LA and thrombosis (36%), and five of 36 healthy control subjects (14%) generated no detectable free t-PA activity after VO (“non-responders”); this difference was not statistically significant. All four “non-responders” with LA and thrombosis had normal t-PA antigen release after VO, indicating that the lack of detectable free t-PA activity after VO was due to increased inhibition of released t-PA. We conclude that abnormally reduced endothelial fibrinolytic activity is not present in the majority of subjects with LA and thrombosis. In the subset of subjects with LA and thrombosis who generate no detectable t-PA activity after VO, a stimulatory effect of LA on endothelial production of t-PA inhibitor cannot be excluded.Keywords
This publication has 21 references indexed in Scilit:
- Thromboembolism in patients with the 'lupus'-type circulating anticoagulantArchives of internal medicine (1960), 1984
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic DiseaseThrombosis and Haemostasis, 1983
- Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.Journal of Clinical Investigation, 1982
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981
- Thrombosis in Patients with the Lupus AnticoagulantAnnals of Internal Medicine, 1980
- PREDISPOSING FACTORS TO THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - POSSIBLE RELATION TO ENDOTHELIAL CELL-DAMAGE1979
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978
- THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS1963